PAVM · PAVmed Inc.
AI read · Neutral
The AI's read
The smaller loss per share points to less loss than a year earlier. But revenue remained at $0.0 million, so the report gives no sign of a sales base supporting stronger business growth.
PAVmed's loss per share narrowed from a year earlier, but reported revenue remained at $0.0 million. Those results point in different directions and do not change how we read the business.
The smaller loss per share points to less loss than a year earlier. But revenue remained at $0.0 million, so the report gives no sign of a sales base supporting stronger business growth.
Follow PAVmed Inc. (PAVM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PAVM